Sign in

You're signed outSign in or to get full access.

VA

Vivek Agarwal

Research Analyst at Citigroup Inc.

United Kingdom

Information not available. The search results do not contain sufficient details about a Vivek Agarwal currently working as an analyst at Citi, including their specific job title, companies covered, performance metrics, career timeline, or professional credentials. Multiple individuals with this name appear in various Citigroup roles, but none match the profile of an equity research analyst with trackable performance data.

Vivek Agarwal's questions to DR REDDYS LABORATORIES (RDY) leadership

Question · Q2 2026

Vivek Agarwal asked about the sustainability of investments in the NRT and branded markets (India, Emerging Markets) and the outlook for absolute OpEx in FY2027.

Answer

CEO Erez Israeli explained that NRT investments are not yet at a steady state, with two more integration waves, and performance is exceeding expectations. CFO Mannam Narasimham advised modeling OpEx (SG&A) in the 28-30% range for future periods.

Ask follow-up questions

Fintool

Fintool can predict DR REDDYS LABORATORIES logo RDY's earnings beat/miss a week before the call